CompanyPharmaceutical ManufacturingDevelopment & TechnologyAnimal HealthInvestor RelationsCareerNews & EventsPress Portal
Aenova increases production capacity for solid dosage forms at Tittmoning site to up to 10 billion tablets per year(04.11.2021)
- The investment project to expand tablet manufacturing capacity is nearing completion; routine operations will start in the first quarter of 2022.
- With the commissioning of the third high-volume line, production capacity at the site increases to over 10 billion tablets per year. An expansion to 12 billion tablets is possible with a short lead time.
- The investment of around € 25 million is in the context of further strategic projects of the Aenova Group.
Press release
1x
2x
Images
Word
LinkedIn
Instagram
Facebook